Nellan et al., in a xenograft murine model using different MB cells lines, showed that the HER2-BBz-CAR T cells effectively eliminated tumour cells via regional and intravenous delivery, although intravenous delivery required a high concentration of effector cells [152]. The gene discussed is ERBB2; the disease is neoplasm.